Cargando…
Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit
BACKGROUND: Few data are available on the impact of levosimendan in refractory cardiogenic shock patients undergoing peripheral venoarterial extracorporeal membrane oxygenation (VA-ECMO). The aim of this study was to evaluate the impact of levosimendan on VA-ECMO weaning in patients hospitalized in...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358626/ https://www.ncbi.nlm.nih.gov/pubmed/30707314 http://dx.doi.org/10.1186/s13613-019-0503-1 |
_version_ | 1783392033495318528 |
---|---|
author | Vally, Shamir Ferdynus, Cyril Persichini, Romain Bouchet, Bruno Braunberger, Eric Lo Pinto, Hugo Martinet, Olivier Vandroux, David Aujoulat, Thomas Allyn, Jérôme Allou, Nicolas |
author_facet | Vally, Shamir Ferdynus, Cyril Persichini, Romain Bouchet, Bruno Braunberger, Eric Lo Pinto, Hugo Martinet, Olivier Vandroux, David Aujoulat, Thomas Allyn, Jérôme Allou, Nicolas |
author_sort | Vally, Shamir |
collection | PubMed |
description | BACKGROUND: Few data are available on the impact of levosimendan in refractory cardiogenic shock patients undergoing peripheral venoarterial extracorporeal membrane oxygenation (VA-ECMO). The aim of this study was to evaluate the impact of levosimendan on VA-ECMO weaning in patients hospitalized in intensive care unit (ICU). METHODS: This retrospective cohort study was conducted in a French university hospital from 2010 to 2017. All patients hospitalized in ICU undergoing VA-ECMO were consecutively evaluated. RESULTS: A total of 150 patients undergoing VA-ECMO were eligible for the study. Thirty-eight propensity-matched patients were evaluated in the levosimendan group and 65 in the non-levosimendan group. In patients treated with levosimendan, left ventricular ejection fraction had increased from 21.5 ± 9.1% to 30.7 ± 13.5% (P < 0.0001) and aortic velocity–time integral from 8.9 ± 4 cm to 12.5 ± 3.8 cm (P = 0.002) 24 h after drug infusion. After propensity score matching, levosimendan was the only factor associated with a significant reduction in VA-ECMO weaning failure rates (hazard ratio = 0.16; 95% confidence interval 0.04–0.7; P = 0.01). Kaplan–Meier survival curves showed that survival rates at 30 days were 78.4% for the levosimendan group and 49.5% for the non-levosimendan group (P = 0.02). After propensity score matching analysis, the difference in 30-day mortality between the two groups was not significant (hazard ratio = 0.55; 95% confidence interval 0.27–1.10; P = 0.09). CONCLUSIONS: Our results suggest that levosimendan was associated with a beneficial effect on VA-ECMO weaning in ICU patients. |
format | Online Article Text |
id | pubmed-6358626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-63586262019-02-24 Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit Vally, Shamir Ferdynus, Cyril Persichini, Romain Bouchet, Bruno Braunberger, Eric Lo Pinto, Hugo Martinet, Olivier Vandroux, David Aujoulat, Thomas Allyn, Jérôme Allou, Nicolas Ann Intensive Care Research BACKGROUND: Few data are available on the impact of levosimendan in refractory cardiogenic shock patients undergoing peripheral venoarterial extracorporeal membrane oxygenation (VA-ECMO). The aim of this study was to evaluate the impact of levosimendan on VA-ECMO weaning in patients hospitalized in intensive care unit (ICU). METHODS: This retrospective cohort study was conducted in a French university hospital from 2010 to 2017. All patients hospitalized in ICU undergoing VA-ECMO were consecutively evaluated. RESULTS: A total of 150 patients undergoing VA-ECMO were eligible for the study. Thirty-eight propensity-matched patients were evaluated in the levosimendan group and 65 in the non-levosimendan group. In patients treated with levosimendan, left ventricular ejection fraction had increased from 21.5 ± 9.1% to 30.7 ± 13.5% (P < 0.0001) and aortic velocity–time integral from 8.9 ± 4 cm to 12.5 ± 3.8 cm (P = 0.002) 24 h after drug infusion. After propensity score matching, levosimendan was the only factor associated with a significant reduction in VA-ECMO weaning failure rates (hazard ratio = 0.16; 95% confidence interval 0.04–0.7; P = 0.01). Kaplan–Meier survival curves showed that survival rates at 30 days were 78.4% for the levosimendan group and 49.5% for the non-levosimendan group (P = 0.02). After propensity score matching analysis, the difference in 30-day mortality between the two groups was not significant (hazard ratio = 0.55; 95% confidence interval 0.27–1.10; P = 0.09). CONCLUSIONS: Our results suggest that levosimendan was associated with a beneficial effect on VA-ECMO weaning in ICU patients. Springer International Publishing 2019-02-01 /pmc/articles/PMC6358626/ /pubmed/30707314 http://dx.doi.org/10.1186/s13613-019-0503-1 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Vally, Shamir Ferdynus, Cyril Persichini, Romain Bouchet, Bruno Braunberger, Eric Lo Pinto, Hugo Martinet, Olivier Vandroux, David Aujoulat, Thomas Allyn, Jérôme Allou, Nicolas Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit |
title | Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit |
title_full | Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit |
title_fullStr | Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit |
title_full_unstemmed | Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit |
title_short | Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit |
title_sort | impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358626/ https://www.ncbi.nlm.nih.gov/pubmed/30707314 http://dx.doi.org/10.1186/s13613-019-0503-1 |
work_keys_str_mv | AT vallyshamir impactoflevosimendanonweaningfromperipheralvenoarterialextracorporealmembraneoxygenationinintensivecareunit AT ferdynuscyril impactoflevosimendanonweaningfromperipheralvenoarterialextracorporealmembraneoxygenationinintensivecareunit AT persichiniromain impactoflevosimendanonweaningfromperipheralvenoarterialextracorporealmembraneoxygenationinintensivecareunit AT bouchetbruno impactoflevosimendanonweaningfromperipheralvenoarterialextracorporealmembraneoxygenationinintensivecareunit AT braunbergereric impactoflevosimendanonweaningfromperipheralvenoarterialextracorporealmembraneoxygenationinintensivecareunit AT lopintohugo impactoflevosimendanonweaningfromperipheralvenoarterialextracorporealmembraneoxygenationinintensivecareunit AT martinetolivier impactoflevosimendanonweaningfromperipheralvenoarterialextracorporealmembraneoxygenationinintensivecareunit AT vandrouxdavid impactoflevosimendanonweaningfromperipheralvenoarterialextracorporealmembraneoxygenationinintensivecareunit AT aujoulatthomas impactoflevosimendanonweaningfromperipheralvenoarterialextracorporealmembraneoxygenationinintensivecareunit AT allynjerome impactoflevosimendanonweaningfromperipheralvenoarterialextracorporealmembraneoxygenationinintensivecareunit AT allounicolas impactoflevosimendanonweaningfromperipheralvenoarterialextracorporealmembraneoxygenationinintensivecareunit |